5-Hydroxytryptamine anxiety

Beginning in the 1960s, ben2odia2epiae anxiolytics and hypnotics rapidly became the standard prescription dmg treatment. In the 1980s, buspkone [36505-84-7] (3), which acts as a partial agonist at the serotonin [50-67-9] (5-hydroxytryptamine, 5-HT) type lA receptor, was approved as treatment for generali2ed anxiety. More recently, selective serotonin reuptake inhibitors (SSRIs) have been approved for therapy of panic disorder and obsessive—compulsive behavior. 

Handley, SL (1995) 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmac. Ther. 66 103-148. 

Serotonin Binds to 5-hydroxytryptamine (5-HT) receptor to act as excitatory and inhibitory neurotransmitter in its inhibitory function, it can treat anxiety and depression in its excitatory function, it is an antipsychotic. 

Griebel G (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders more than 30 years of research. Pharmacol Ther 65 319-395 Griebel G, Belzung C, Perrault G, Sanger DJ (2000) Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 148 164-170... 

The neurotransmitter serotonin (5-hydroxytryptamine [5-HT]) is widely distributed in the CNS, subsuming a variety of functions including drive satiety, mood, aggression, anxiety, and compulsive and impulsive behaviors. It may be an important neurotransmitter in psychiatric symptoms commonly associated with PTSD such as aggression, obsessive/intrusive thoughts, alcohol and substance abuse, and suicidal behavior (Friedman, 1990). Suicidal behavior is known to be associated with both childhood maltreatment and low 5-HT functioning (Van der Kolk et ah, 1991 Benkelfat,... 

Serotonin (also known as 5-hydroxytryptamine) is released by cells originating in the midline of the pons and brainstem and is projected to many different areas, including the dorsal horns of the spinal cord and the hypothalamus. Serotonin is considered to be a strong inhibitor in most areas of the CNS and is believed to be important in mediating the inhibition of painful stimuli. It is also involved in controlling many aspects of mood and behavior, and problems with serotonergic activity have been implicated in several psychiatric disorders, including depression and anxiety.12,17 The roles of serotonin and the other monoamines in psychiatric disorders are discussed in Chapters 6-8. 

Part of the membrane lying adjacent to the nerve terminal that contains the postsynaptic receptors. Anxiety disorder attributed to a severe, adverse life experience (e.g. threat to life) that is experienced again without the stimulus of the adverse experience. Usually used in reference to compounds which are metabolized in neurotransmitters (e.g. tryptophan is the precursor of 5-hydroxytryptamine). 

Strobel A, Gutknecht L, Rothe C, Reif A, Mossner R, Zeng Y, Brocke B, Lesch KP. Allelic variation in 5-HT 1A receptor expression is associated with anxiety- and depression-related personality traits. J. Neural Transm. 2003 110 1445-1453. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, et al. Impaired repression at a 5-hydroxytryptamine lA receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 2003 23 8788-8799. 

BMY 13805-1 MJ 13805) is one of the azaspirone group structurally related to buspirone and with similar properties. It is a 5-hydroxytryptamine receptor agonist, a partial agonist at the 5HTi receptor subtype. It is a novel ANXIOLYTIC under investigation for treatment of anxiety and depression. 

Serotonin (S-hydroxytryptamine, 5-HT)-augmenting antidepressants are effective for treating premenstrual and perimenopausal mood and anxiety symptoms. Serotonin reuptake inhibitors (SRIs) may be given continuously or intermittently during the luteal phase of the menstrual cycle for PMDD. 

Serotonin (5-hydroxytryptamine 5-HT) is involved in the regulation of the cardiovascular and respiratory systems, sleep, aggression, sexual behavior, food intake, anxiety, mood, motor output, neuroendocrine secretion, nociception, and analgesia. 

Alterations in 5-hydroxytryptamine (5-HT) neurotransmission have been implicated in a number of human disorders such as migraine, depression and anxiety as well as in normal human functions such as sleep, sexual activity and appetite. Unfortunately, the scientific association between 5-HT and these disorders has been largely suggestive rather than definitive. Nonetheless, recent advances in the understanding of 5-HT receptor subtypes have strengthened the ability to document specific links between modulation of 5-HT neurotransmission and human disease states. This brief chapter will present an overview of the current status of 5-HT receptor subtypes. 

In view of the importance of the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) in the etiology or treatment of numerous medical problems (anxiety, depression, stroke, migraine. 

Serotonin (5-hydroxytryptamine, 5-HT) occurs in the intestinal wall, where it regulates motility and secretion in blood platelets, where it modulates platelet aggregation and vascular blood flow and in the CNS, where it acts as a neurotransmitter in areas of the midbrain. At least seven different receptors for serotonin have been characterized, which mediate a wide variety of different physiological effects. Depression and anxiety are thought to be the result of actions on 5-HTia receptors in the brain limbic system. Following release from neurons by a depolarizing action potential at central synapses, the activity of 5-HT is terminated by neuronal reuptake. This is performed by a synaptic membrane amine transporter protein, specific for 5-HT, which also co-transports sodium and chloride ions to repolarize the neuronal membrane. 

Monoester 4-(methoxycarbonyl)bicyclo[2.2.1]heptane-l-carboxylic acid 59 (Figure 4.17) is a building block of many potential therapeutic candidates for inhibitors of 11-p-hydroxysteroid dehydrogenase type 1 enzyme and their use in the treatment of non-insulin-dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and CNS disorders. It is also required for the synthesis of 5-hydroxytryptamine receptor agonists, useful for the treatment of anxiety disorders and schizophrenia [90,91]. 

---